|
Market Closed -
Bombay S.E.
13:24:18 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 30.40 INR | +2.01% |
|
+2.43% | -36.21% |
| Market Cap | 1.07B 11.19M 9.82M 9.27M 8.45M 15.82M 15.93M 111M 42.97M 548M 42M 41.09M 1.76B | P/E 2025 |
-22.5x | P/E 2026 | -8.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 13.94M 12.23M 11.55M 10.53M 19.71M 19.85M 138M 53.55M 683M 52.34M 51.21M 2.19B | EV / Sales 2025 |
14.5x | EV / Sales 2026 | 4.45x |
| Free-Float |
25.69% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +2.01% | ||
| 1 week | +2.43% | ||
| Current month | -4.37% | ||
| 1 month | -1.11% | ||
| 3 months | -11.40% | ||
| 6 months | -3.43% | ||
| Current year | -36.21% |
| 1 week | 29.33 |  | 30.8 |
| 1 month | 29.15 | | 33.97 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 66 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | +2.43% | -48.28% | -23.81% | 10.95M | |
| +0.13% | +2.69% | +59.53% | +114.96% | 1,053B | |
| +0.20% | +0.37% | +53.50% | +68.98% | 652B | |
| -0.29% | +0.12% | +20.16% | +73.07% | 468B | |
| -0.85% | -0.25% | +38.63% | +44.47% | 351B | |
| +0.71% | +3.26% | +22.46% | +30.30% | 273B | |
| +1.23% | +1.00% | +11.97% | +13.63% | 254B | |
| +2.11% | +9.17% | +48.49% | +54.88% | 220B | |
| +0.83% | +0.03% | +32.78% | +101.21% | 186B | |
| 0.00% | -9.43% | -31.91% | -60.56% | 170B | |
| Average | +0.55% | +0.31% | +20.73% | +41.71% | 362.74B | |
| Weighted average by Cap. | +0.25% | +1.00% | +38.89% | +68.42% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 194M 2.03M 1.78M 1.68M 1.53M 2.87M 2.89M 20.12M 7.79M 99.35M 7.62M 7.45M 319M | 279M 2.91M 2.55M 2.41M 2.2M 4.11M 4.14M 28.85M 11.17M 142M 10.92M 10.69M 458M |
| Net income | -108M -1.12M -987K -932K -849K -1.59M -1.6M -11.15M -4.32M -55.06M -4.22M -4.13M -177M | -117M -1.22M -1.07M -1.01M -923K -1.73M -1.74M -12.12M -4.7M -59.86M -4.59M -4.49M -192M |
| Net Debt | 399M 4.16M 3.65M 3.45M 3.14M 5.88M 5.93M 41.27M 15.98M 204M 15.62M 15.29M 655M | 264M 2.75M 2.42M 2.28M 2.08M 3.89M 3.92M 27.32M 10.58M 135M 10.34M 10.12M 434M |
Employees
127
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | ₹30.40 | +2.01% | 2,285 |
| 24/09/26 | ₹29.80 | -1.03% | 1,677 |
| 23/09/26 | ₹30.11 | +1.59% | 2,525 |
| 22/09/26 | ₹29.64 | -0.34% | 851 |
| 21/09/26 | ₹29.74 | +0.20% | 3,151 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
